Idiopathic noncirrhotic portal hypertension

Hepatology

Volumn 54, Issue 3, 2011, Pages 1071-1081

  Schouten, Jeoffrey N L ^a   Garcia Pagan, Juan C ^b   Valla, Dominique C ^c   Janssen, Harry L A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ARSENIC; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSULFAN; CARDIOLIPIN ANTIBODY; DIDANOSINE; ENDOTHELIN 1; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; MERCAPTOPURINE; NITRIC OXIDE; PROSTACYCLIN; TIOGUANINE; TOXIN;

ABDOMINAL INFECTION; ADAMS OLIVER SYNDROME; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CHRONIC MYELOID LEUKEMIA; COHORT ANALYSIS; CULTURAL ANTHROPOLOGY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; ECHOGRAPHY; ELASTOGRAPHY; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESCHERICHIA COLI; ESOPHAGUS HEMORRHAGE; ETHNIC DIFFERENCE; GASTROINTESTINAL HEMORRHAGE; GENETIC DISORDER; GENETIC PREDISPOSITION; GROUPS BY AGE; HEMATOLOGIC DISEASE; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HEPATOPULMONARY SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HISTORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; HYPERSPLENISM; IDIOPATHIC NONCIRRHOTIC PORTAL HYPERTENSION; IMMUNOGENETICS; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPATHOLOGY; INCIDENCE; INDIA; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; KIDNEY FAILURE; LIVER ATROPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER HEMORRHAGE; LIVER HISTOLOGY; LIVER HYPERPLASIA; LIVER PARENCHYMA; LIVER TRANSPLANTATION; MALARIA; MEMBRANE DAMAGE; MICROCIRCULATION; MICROTHROMBUS; MORTALITY; NODULAR HYPERPLASIA; PATHOLOGY; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN OBSTRUCTION; PORTAL VEIN THROMBOSIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROPHYLAXIS; REMISSION; RETROSPECTIVE STUDY; SCREENING; SEX DIFFERENCE; SOCIAL CLASS; SPLEEN BLOOD FLOW; SPLEEN CELL; SPLENECTOMY; SPLENOMEGALY; STOMACH VARICES; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THROMBOPHILIA; THROMBUS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TURNER SYNDROME; UPPER GASTROINTESTINAL BLEEDING; VASCULAR DISEASE; VASCULAR PATENCY; VASCULAR RESISTANCE;

HUMANS; HYPERTENSION, PORTAL; PROGNOSIS;

EID: 80052028596     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24422     Document Type: Article

References (100)

1. Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology 2008; 134: 1715-1728.
2. De Cock KM. Hepatosplenic schistosomiasis: a clinical review. Gut 1986; 27: 734-745.
3. Garcia-Pagan JC, Hernandez-Guerra M, Bosch J. Extrahepatic portal vein thrombosis. Semin Liver Dis 2008; 28: 282-292.
4. Valla DC. Primary Budd-Chiari syndrome. J Hepatol 2009; 50: 195-203.
5. Francque S, Verrijken A, Mertens I, Hubens G, Van Marck E, Pelckmans P, et al. Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension. Int J Obes (Lond) 2011; 35: 270-278.
6. Hillaire S, Bonte E, Denninger MH, Casadevall N, Cadranel JF, Lebrec D, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002; 51: 275-280.
7. Banti. Beitrage zur pathologischen Anat. Allgemeinea Pathol 1889; 24: 21-33.
8. Basu AK, Boyer J, Bhattacharya R, Mallik KC, Sen Gupta KP. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res 1967; 55: 336-350.
9. Sama SK, Bhargava S, Nath NG, Talwar JR, Nayak NC, Tandon BN, Wig KL. Noncirrhotic portal fibrosis. Am J Med 1971; 51: 160-169.
10. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002; 17: 6-16.
11. Sarin SK, Kumar A, Chawla YK, Baijal SS, Dhiman RK, Jafri W, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int 2007; 1: 398-413.
12. Iber FL. Obliterative portal venopathy of the liver and "idiopathic portal hypertension". Ann Intern Med 1969; 71: 660-661.
13. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2, 500 autopsies and a new classification of benign hepatocellular nodules. HEPATOLOGY 1990; 11: 787-797.
14. Villeneuve JP, Huet PM, Joly JG, Marleau D, Cote J, Legare A, et al. Idiopathic portal hypertension. Am J Med 1976; 61: 459-464.
15. Kingham JG, Levison DA, Stansfeld AG, Dawson AM. Non-cirrhotic intrahepatic portal hypertension: a long term follow-up study. Q J Med 1981; 50: 259-268.
16. Nevens F, Staessen D, Sciot R, Van Damme B, Desmet V, Fevery J, et al. Clinical aspects of incomplete septal cirrhosis in comparison with macronodular cirrhosis. Gastroenterology 1994; 106: 459-463.
17. Eapen CE, Nightingale P, Hubscher SG, Lane PJ, Plant T, Velissaris D, Elias E. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci 2011; 56: 227-235.
18. Moran CA, Mullick FG, Ishak KG. Nodular regenerative hyperplasia of the liver in children. Am J Surg Pathol 1991; 15: 449-454.
19. Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut 2004; 53: 1032-1034.
20. Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T. Idiopathic portal hypertension associated with progressive systemic sclerosis. Am J Gastroenterol 1982; 77: 645-648.
21. Tsuneyama K, Harada K, Katayanagi K, Watanabe K, Kurumaya H, Minato H, Nakanuma Y. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol 2002; 17: 217-223.
22. Carreras LO, Defreyn G, Machin SJ, Vermylen J, Deman R, Spitz B, Van Assche A. Arterial thrombosis, intrauterine death, and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246.
23. Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008; 48: 74-82.
24. Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 2002; 17: 526-534.
25. Kono K, Ohnishi K, Omata M, Saito M, Nakayama T, Hatano H, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 1988; 94: 787-796.
26. Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J. Response to Mallet et al., "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients". AIDS 2007; 21: 1494-1495.
27. Maida I, Garcia-Gasco P, Sotgiu G, Rios MJ, Vispo ME, Martin-Carbonero L, et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors, and outcome. Antivir Ther 2008; 13: 103-107.
28. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, Pol S. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007; 21: 187-192.
29. Mallet VO, Bralet MP, Pol S. Response to Schiano et al. "Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV". Am J Gastroenterol 2008; 103: 808-809.
30. Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007; 102: 2536-2540.
31. Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008; 6: 1167-1169.
32. Chang PE, Miquel R, Blanco JL, Laguno M, Bruguera M, Abraldes JG, et al. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009; 104: 1707-1714.
33. Vispo E, Moreno A, Maida I, Barreiro P, Cuevas A, Albertos S, Soriano V. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS 2010; 24: 1171-1176.
34. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5: e203.
35. Guha Mazumdar DN, Das Gupta J. Arsenic and non-cirrhotic portal hypertension. J Hepatol 1991; 13: 376.
36. Mazumder DN, Das Gupta J, Santra A, Pal A, Ghose A, Sarkar S. Chronic arsenic toxicity in west Bengal-the worst calamity in the world. J Indian Med Assoc 1998; 96: 4-7, 18.
37. Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol 1990; 11: 80-85.
38. Key NS, Kelly PM, Emerson PM, Chapman RW, Allan NC, McGee JO. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia. Lancet 1987; 2: 1050-1052.
39. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12: 60-71.
40. De Boer NK, Tuynman H, Bloemena E, Westerga J, Van Der Peet DL, Mulder CJ, et al. Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia. Scand J Gastroenterol 2008; 43: 604-608.
41. Vernier-Massouille G, Cosnes J, Lemann M, Marteau P, Reinisch W, Laharie D, et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56: 1404-1409.
42. Roulot D, Degott C, Chazouilleres O, Oberti F, Cales P, Carbonell N, et al. Vascular involvement of the liver in Turner's syndrome. HEPATOLOGY 2004; 39: 239-247.
43. Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol 1987; 82: 1130-1133.
44. Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E. Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A 2005; 135: 186-189.
45. Barnett JL, Appelman HD, Moseley RH. A familial form of incomplete septal cirrhosis. Gastroenterology 1992; 102: 674-678.
46. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003; 42: 251-264.
47. Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology 1993; 22: 227-234.
48. Nakanuma Y, Hoso M, Sasaki M, Terada T, Katayanagi K, Nonomura A, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28: 195-204.
49. Cazals-Hatem D, Hillaire S, Rudler M, Plessier A, Paradis V, Condat B, et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 2011; 54: 455-461.
50. Ohnishi K, Saito M, Sato S, Terabayashi H, Iida S, Nomura F, et al. Portal hemodynamics in idiopathic portal hypertension (Banti's syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology 1987; 92: 751-758.
51. Blendis LM, Banks DC, Ramboer C, Williams R. Spleen blood flow and splanchnic haemodynamics in blood dyscrasia and other splenomegalies. Clin Sci 1970; 38: 73-84.
52. Sato Y, Sawada S, Kozaka K, Harada K, Sasaki M, Matsui O, Nakanuma Y. Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension. Dig Dis Sci 2007; 52: 1987-1994.
53. Dabritz J, Worch J, Materna U, Koch B, Koehler G, Duck C, et al. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol 2010; 10: 122.
54. Lindor K, Rakela J, Perrault J, Van Heerden J. Noncirrhotic portal hypertension due to lymphoma. Reversal following splenectomy. Dig Dis Sci 1987; 32: 1056-1058.
55. Babbs C, Warnes TW, Torrance HB, Ballardie FW. IgA nephropathy in non-cirrhotic portal hypertension. Gut 1991; 32: 225-226.
56. Saito K, Nakanuma Y, Takegoshi K, Ohta G, Obata Y, Okuda K, Kameda H. Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology 1993; 40: 163-166.
57. Nakanuma Y, Sato Y, Kiktao A. Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension: hints from systemic sclerosis. Hepatol Res 2009; 39: 1023-1031.
58. Kamath PS, Carpenter HA, Lloyd RV, McKusick MA, Steers JL, Nagorney DM, Miller VM. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver. Liver Transpl 2000; 6: 596-602.
59. Sarin SK. Non-cirrhotic portal fibrosis. J Gastroenterol Hepatol 2002; 17(Suppl 3): S214-S223.
60. Okuda K, Kono K, Ohnishi K, Kimura K, Omata M, Koen H, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 1984; 86: 600-610.
61. McDonald JA, Painter DM, Gallagher ND, McCaughan GW. Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut 1990; 31: 725-727.
62. Radomski JS, Chojnacki KA, Moritz MJ, Rubin R, Armenti VT, Wilson GA, et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000; 66: 1067-1070.
63. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005; 11: 627-634; discussion, 610-621.
64. Babbs C, Warnes TW, Haboubi NY. Non-cirrhotic portal hypertension with hypoxaemia. Gut 1988; 29: 129-131.
65. Kaymakoglu S, Kahraman T, Kudat H, Demir K, Cakaloglu Y, Adalet I, et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci 2003; 48: 556-560.
66. De BK, Sen S, Sanyal R. Hepatopulmonary syndrome in noncirrhotic portal hypertension. Ann Intern Med 2000; 132: 924.
67. Seijo S RE, Berzigotti A, Abraldes JG, Bruguera M, Bosch J, Garcia-Pagan JC. Idiopathic portal hypertension: impact of hepatic vein catheterization and transient elastography on its diagnosis. J Hepatol 2010; 52: S172.
68. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005; 41: 48-54.
69. Okuda K, Nakashima T, Okudaira M, Kage M, Aida Y, Omata M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver 1982; 2: 176-192.
70. Sawada S, Sato Y, Aoyama H, Harada K, Nakanuma Y. Pathological study of idiopathic portal hypertension with an emphasis on cause of death based on records of Annuals of Pathological Autopsy Cases in Japan. J Gastroenterol Hepatol 2007; 22: 204-209.
71. International Working Party. Terminology of nodular hepatocellular lesions. HEPATOLOGY 1995; 22: 983-993.
72. Bioulac-Sage P, Le Bail B, Bernard PH, Balabaud C. Hepatoportal sclerosis. Semin Liver Dis 1995; 15: 329-339.
73. Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension. HEPATOLOGY 1993; 17: 1157-1162.
74. Sherlock S, Feldman CA, Moran B, Scheuer PJ. Partial nodular transformation of the liver with portal hypertension. Am J Med 1966; 40: 195-203.
75. Wanless IR, Lentz JS, Roberts EA. Partial nodular transformation of liver in an adult with persistent ductus venosus. Review with hypothesis on pathogenesis. Arch Pathol Lab Med 1985; 109: 427-432.
76. Sciot R, Staessen D, Van Damme B, Van Steenbergen W, Fevery J, De Groote J, Desmet VJ. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988; 13: 593-603.
77. Popper H. Pathogenesis and classification of liver cirrhosis [in German]. Med Klin 1969; 64: 89-92.
78. Bernard PH, Le Bail B, Cransac M, Barcina MG, Carles J, Balabaud C, Bioulac-Sage P. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol 1995; 22: 495-499.
79. Ohbu M, Okudaira M, Watanabe K, Kaneko S, Takai T. Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension. HEPATOLOGY 1994; 20: 302-308.
80. Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 1969; 87: 359-369.
81. Isabel Fiel M, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007; 31: 607-614.
82. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990; 12: 460-465.
83. Tsuneyama K, Ohba K, Zen Y, Sato Y, Niwa H, Minato H, Nakanuma Y. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 2003; 43: 55-61.
84. Matsutani S, Maruyama H, Akiike T, Kobayashi S, Yoshizumi H, Okugawa H, et al. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan. Liver Int 2005; 25: 978-983.
85. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-689.
86. Amitrano L, Brancaccio V, Guardascione MA, Margaglione M, Sacco M, Martino R, et al. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy 2002; 34: 535-538.
87. Colina F, Alberti N, Solis JA, Martinez-Tello FJ. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989; 9: 253-265.
88. Nzeako UC, Goodman ZD, Ishak KG. Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol 1996; 91: 879-884.
89. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010; 53: 762-768.
90. Chawla YK, Dilawari JB, Dhiman RK, Goenka MK, Bhasin DK, Kochhar R, et al. Sclerotherapy in noncirrhotic portal fibrosis. Dig Dis Sci 1997; 42: 1449-1453.
91. Sarin SK, Nanda R, Kumar N, Vij JC, Anand BS. Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg 1985; 202: 708-711.
92. Bhargava DK, Dasarathy S, Sundaram KR, Ahuja RK. Efficacy of endoscopic sclerotherapy on long-term management of oesophageal varices: a comparative study of results in patients with cirrhosis of the liver, non-cirrhotic portal fibrosis (NCPF) and extrahepatic portal venous obstruction (EHO). J Gastroenterol Hepatol 1991; 6: 471-475.
93. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification, and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. HEPATOLOGY 1992; 16: 1343-1349.
94. Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992; 102: 994-999.
95. Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. HEPATOLOGY 1987; 7: 437-441.
96. Romano M, Giojelli A, Capuano G, Pomponi D, Salvatore M. Partial splenic embolization in patients with idiopathic portal hypertension. Eur J Radiol 2004; 49: 268-273.
97. Hirota S, Ichikawa S, Matsumoto S, Motohara T, Fukuda T, Yoshikawa T. Interventional radiologic treatment for idiopathic portal hypertension. Cardiovasc Intervent Radiol 1999; 22: 311-314.
98. Valla DC. Thrombosis and anticoagulation in liver disease. HEPATOLOGY 2008; 47: 1384-1393.
99. Dumortier J, Bizollon T, Scoazec JY, Chevallier M, Bancel B, Berger F, et al. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001; 36: 417-422.
100. Loinaz C, Colina F, Musella M, Lopez-Rios F, Gomez R, Jimenez C, et al. Orthotopic liver transplantation in 4 patients with portal hypertension and non-cirrhotic nodular liver. Hepatogastroenterology 1998; 45: 1787-1794.